Nuevas
noticias
Desarrollamos nuevas terapias basadas en siRNA para evitar el deterioro de la estructura y función cardiaca
Bienvenidos a BIOCARDIO
Especialistas en investigación cardiovascular
Empresa de Base Tecnológica promovida por investigadores clínicos y experimentales, que nace en el seno de la Universidad de Murcia, cuya misión es el desarrollo de mejoras terapéuticas y diagnósticas para pacientes con enfermedades cardiovasculares.
Artículos recientes
Menú
DYSTROPHIA MYOTONICA
PROTEIN KINASE (DMPK).
- What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text
DYSTROPHIA MYOTONICA
PROTEIN KINASE (DMPK).
- What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text
DYSTROPHIA MYOTONICA
PROTEIN KINASE (DMPK).
- What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text
DYSTROPHIA MYOTONICA
PROTEIN KINASE (DMPK).
- What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text
DYSTROPHIA MYOTONICA
PROTEIN KINASE (DMPK).
- What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text
DYSTROPHIA MYOTONICA
PROTEIN KINASE (DMPK).
- What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text
Lo hacemos todo por ti, consúltanos sin ningún compromiso
Empresa de Base Tecnológica promovida por investigadores clínicos y experimentales, cuya misión es el desarrollo de mejoras terapéuticas y diagnósticas para pacientes con enfermedades cardiovasculares.
